Sarcoidosis
Title:
Ñ
Sarcoidosis
Definition:
Ñ
Sarcoidosis is a multisystem
granulomatous disorder
Ñ
It usually affects young adults
and presents with bilateral hilar lymphadenopathy, pulmonary infiltration,
skin and eye lesions.
Aetiology:
Ñ
Unknown
Pathogenesis
Ñ
The characteristic lesion in
sarcoidosis is the granuloma
Ñ
Sarcoid granulomas are formed by
accumulations of epithelioid histiocytes often including giant cells and
lymphocytes (mainly T)
Ñ
Schaumann bodies (laminated,
calcified proteinaceous concretions) may be present
Ñ
Asteroid bodies (stellate
inclusions within giant cells) may occur
Clinical Features:
History:
Ñ
Peak incidence 3rd
and 4th decades
Ñ
Females > Males
E&M:
Ñ
Fatigue
Ñ
Weight loss
Ñ
Fever
RS:
Ñ
Dyspnoea
CNS:
Ñ
Seizures
Examination:
IS:
Ñ
Erythema nodosum
Ñ
Lupus pernio
CVS:
Ñ
Conduction defects
Ñ
Ventricular dysrhythmias
Ñ
Cardiomyopathy
Ñ
Cor pulmonale
RS:
Ñ
Pulmonary infiltration
GIT:
Ñ
Keratoconjunctivitis sicca
Ñ
Uveoparotid fever:
Bilateral uveitis and parotid enlargement
sometimes associated with facial palsy
Ñ
Hepatosplenomegaly
CNS:
Ñ
Uveitis
Ñ
Conjunctivitis
Ñ
Retinal lesions
Ñ
Cranial nerve palsies
Ñ
Transverse myelitis
Ñ
Peripheral neuropathy
Ñ
Meningism
LMS:
Ñ
Bone cysts:
Particularly in the digits
Investigations:
Fluids:
Blood
Biochemistry:
Ñ
Raised serum calcium:
Alpha hydroxylation of 25
hydroxycholecalciferol to 1,25 dihydroxycholecalciferol takes place in sarcoid
macrophages in the lungs
This increases levels of calcitriol in the
blood and results in hypercalcaemia
Ñ
Ñ
Elevated serum ACE:
Useful in assessing activity of the disease
Imaging:
CXR:
Ñ
Bilateral hilar lymphadenopathy
Ñ
Mottling in the mid-zones
Ñ
Generalised fine nodular shadows
Ñ
Pulmonary line shadows
Ñ
Honeycomb appearance
Staging of Thoracic Sarcoid:
Ñ
Stage 1:
Normal
Ñ
Stage 2:
Hilar lymphadenopathy
Ñ
Stage 3:
Hilar lymphadenopathy + parenchymal infiltrate
Ñ
Stage 4
Parenchymal infiltrate+fibrosis
High
Resolution CT Scan
Ñ
Show features characteristic of
sarcoid
Physiological assessment
Lung Function Tests:
Ñ
Decreased TLC
Ñ
Decrease in FEV1 and
FVC
Ñ
Decreased gas transfer
Endoscopy
Bronchoscopy and Bronchoalveolar Lavage (BAL)
Ñ
30 % lymphocyte counts
Ñ
Normal 10%
Ñ
May be as high as 50-60% in
florid cases
Tissue Diagnosis:
Transbronchial lung biopsy:
Ñ
Positive in 90%
Management:
Control
Drugs:
Ñ
Steroids
Ñ
Immunosuppressive agents:
Methotrexate, azathioprine, ciclosporin
Ñ
Chloroquine
Indications for Steroids:
Ñ
No
spontaneous improvement in pulmonary disease 6 months after diagnosis
Ñ
Eye involvement
Ñ
Persistent hypercalcaemia
Ñ
Severe erythema nodosum
Ñ
Uveoparotid fever
Ñ
Myocardial sarcoid
Ñ
Neurological manifestations
Prognosis
Thoracic
Ñ
60% thoracic sarcoid resolves
spontaneously
Ñ
20% resolve with steroids, which
may then be discontinued
Ñ
10-20% chronic disease
Chronic extrathoracic sarcoid
Ñ
Responds poorly to treatment
Ñ
CNS poor response